On the pre-clinical validation of a commercial model-based optimisation engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the performance of a model-based optimisation process for volumetric modulated
arc therapy applied to advanced lung cancer and to low risk prostate carcinoma patients.